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2 Abstract 
In this thesis, we examine ex-vivo human carotid arterial vessel walls and atherosclerotic plaque features 
by phase-contrast imaging (PCI) using a synchrotron-based as well as a lab-based set-up. We compare 
results from PCI to histopathology as gold standard. PCI is an X-ray-based imaging method providing 
better soft tissue contrast than conventional X-ray imaging techniques. Unlike conventional X-ray 
methods, which are based on the attenuation of the X-ray beam, PCI relies on the phase-shift of X-rays 
when passing through matter. A lab-based PCI set-up has the potential for future clinical application.  
In the first part, we performed phase-contrast computed tomography (PC-CT) at a synchrotron facility on 
five carotid artery specimens at two different photon energies, 23 keV and 53 keV, where the higher 
photon energy is in a clinically applicable range.  In healthy specimens qualitative and quantitative 
features of the vessel wall were assessed at both photon energies. In diseased specimens plaque features 
including fibrous tissue, lipid, necrotic core (NEC), intraplaque hemorrhage (IPH), inflammatory cell 
infiltration and calcifications (CAs) were evaluated at 53 keV concerning qualitative and quantitative 
characteristics including phase-contrast Hounsfield units (HU-phase). Healthy samples had the same 
signal characteristics at 23 keV and 53 keV with tunica intima and adventitia showing bright signal, and 
tunica media showing dark signal. Plaque components at 53 keV showed different signal intensities, 
texture and HU-phase. In summary, the potential of PC-CT for the visualization and quantification of 
atherosclerotic plaque at clinically applicable photon energies could be demonstrated in this study. 
In the second part of the thesis two carotid endarterectomy specimens were investigated at a synchrotron-
based PC-CT set-up at 23 keV and three specimens at a lab-based set-up with a conventional X-ray tube 
(35-40 kVp; 70 mA). During the imaging process absorption-based images were also obtained. The 
determination of signal-to-noise ratio (SNR) between PC-CT and absorption images showed higher 
SNRs in synchrotron-based images compared to laboratory-based images and superior SNRs in both PC-
CT set-ups compared to absorption-based images. Two independent evaluators determined vessel 
dimensions in a manual measurement. All PCI-based measurements showed high correlation with 
significant overestimation of lumen, intima as well as vessel wall area for both set-ups, as compared with 
histology. Reproducibility between readers was excellent. Overall, in this study, we demonstrated that 
PC-CT of carotid specimens and in particular the identification of vessel wall structures is feasible with 
both synchrotron and conventional X-ray sources. 
In the third study plaque features of seven carotid artery specimens were assessed by PC-CT using a lab-
based set-up. Characteristics of the NEC, fibrous cap (FC), IPH, and CAs were established. Sensitivity, 
specificity and accuracy of PC-CT for plaque identification as well as the potential for quantification 
were evaluated. PC-CT showed good sensitivity for detection of NEC, FC, IPH, and CAs as well as 
excellent specificity and accuracy, with good agreement between readers. The correlations for 
quantitative measurements of NEC, FC, and CAs between PCI and histopathology were excellent as well 
as the reproducibility between readers. In this study, we demonstrated that lab-based PC-CT is suitable 
for identification and quantification of atherosclerotic plaque components and has potential for clinical 
applications. 
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3 Zusammenfassung 
In der vorliegenden Arbeit wurden humane Carotisarterien ex-vivo bezüglich der Beschaffenheit der 
Wandschichten und atherosklerotischer Plaqueanteile mittels Phasenkontrastbildgebung (PCI) mit einer 
Synchrotronquelle und mit einer konventionellen  labor-basierten Röntgenquelle untersucht. Eine 
histologische Vermessung der Proben diente als Goldstandard für den Vergleich der  
Phasenkontrastdaten. PCI ist eine röntgenbasierte Bildgebungsmethode mit verbessertem 
Weichteilkontrast im Vergleich zu konventionellen röntgenbasierten Techniken.  PCI basiert auf der 
Phasenverschiebung von Röntgenstrahlen durch Materie, während konventionelle Techniken auf der 
Abschwächung der Röntgenstrahlung durch Absorption beruhen. Der PCI Laboraufbau birgt Potential 
für eine zukünftige klinische Anwendbarkeit.  
In der ersten Studie wurden fünf Proben von Carotisarterien mittels Phasenkontrastcomputertomographie 
(PC-CT) in einem Synchrotronaufbau bei zwei verschiedenen Photonenenergien (23 keV und 53 keV) 
untersucht. Die höhere Photonenenergie liegt im Bereich klinischer CT Anwendungen. Es erfolgte eine 
qualitative und quantitative Analyse der Arterienwand bei beiden Photonenenergien. Pathologisch 
veränderte Proben mit Plaquestrukturen wie fibröses Gewebe, fetthaltiges Gewebe, nekrotischer Kern 
(NEC), Einblutung in den Plaque (IPH), Infiltration inflammatorischer Zellen und Verkalkungen (CAs) 
wurden bei einer Photonenenergie von 53 keV bezüglich qualitativer und quantitativer Charakteristika 
einschließlich Phasenkontrast Hounsfield-Einheiten (HU-phase) untersucht. Proben ohne Pathologie 
zeigten dieselben Charakteristika bei beiden Photonenenergien, wobei die Tunica intima und adventitia 
hell und die Tunica media dunkel erschien. Plaquekomponenten die bei 53 keV untersucht wurden, 
wiesen verschiedene Signalintensitäten, Gewebeeigenschaften und HU-phase auf. Zusammenfassend 
konnte in dieser Studie das Potential von PC-CT für die Darstellung und quantitative Auswertung von 
atherosklerotischen Plaques mit für klinische Anwendungen üblichen Photonenenergien demonstriert 
werden. 
Im zweiten Teil dieser Arbeit wurden zwei Carotisendarterektomie-Präparate an einem Synchrotron-
Aufbau  mit 23 keV und drei Proben an einem Aufbau mit konventioneller Röntgenröhre (35-40 kVp; 70 
mA) untersucht.  Während des Bildgebungsprozesses wurden auch Absorptionsbilder aufgenommen. Es 
zeigten sich höhere Signal-zu-Rausch-Verhältnisse (SNR) zwischen PC-CT- und Absorptionsbildern in 
den Synchrontronaufnahmen im Vergleich zu Aufnahmen mit  konventioneller Röntgenröhre.  Die PC-
CT-Aufnahmen zeigten in beiden Aufbauten höhere SNR im Vergleich zu den Absorptionsbildern. Zwei 
unabhängige Auswerter werteten die Arterienschnitte quantitativ aus.   In allen Phasenkontrastaufnahmen 
zeigten die so ermittelten Messwerte eine hohe Prädiktion mit jedoch signifikanter Überschätzung im 
Vergleich zu den Messwerten aus den histologischen Schnittbildern sowie eine hohe Interobserver-
Reproduzierbarkeit. In dieser Studie zeigte sich, dass mittels PC-CT die Identifikation verschiedener 
Strukturen der Arterienwand sowohl an einem Synchrotronaufbau, als auch an einem Laboraufbau mit 
konventioneller Röntgenröhre möglich ist.  
In der dritten Studie wurden Plaquekomponenten von sieben Karotisendarterektomiepräparaten mittels 
PC-CT an einem konventionellen Laboraufbau untersucht. Merkmale von NEC mit einer fibrösen Kappe 
(FC), IPH und CAs wurden beschrieben. Untersucht wurde die Sensitivität, Spezifität und Genauigkeit 
von PC-CT bei der Identifikation und Quantifizierung von Plaques. PC-CT erreichte eine gute 
Sensitivität bei der Detektion von FC, NEC, IPH und CAs sowie eine hohe Spezifität und Genauigkeit 
mit guter Übereinstimmung zwischen unabhängigen Auswertern. Neben einer signifikanten 
Überschätzung  der Lumenfläche zeigte sich eine hohe Korrelation der quantitativen Messwerten von 
FC, NEC, CAs zwischen PCI und Histopathologie sowie eine hohe Reproduzierbarkeit zwischen den 
unabhängigen Auswertern. Zusammenfassend zeigte diese Studie, dass ein konventioneller PC-CT 
Aufbau geeignet ist Plaque-Komponenten zu identifizieren und zu quantifizieren und daher potentiell für  
klinische Applikation angewendet werden könnte. 
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4 Motivation and aims of the thesis 
Atherosclerosis is a common disease, in which the formation of plaques potentially leads to the occlusion 
of an arterial lumen by a thromoboembolic event, e.g. resulting in myocardial infarction or ischemic 
stroke.  These diseases belong to the most common diseases in the world and are associated with high 
mortality and morbidity1.  The identification of atherosclerotic plaques and features associated with a 
high risk for ischemic events still remains a challenge using conventional imaging techniques2. Phase-
contrast imaging (PCI) is a relatively new X-ray-based imaging method which provides better soft tissue 
contrast compared to conventional X-ray-based imaging techniques3. The aim of the thesis was a 
preclinical ex-vivo evaluation of human carotid arteries to assess the potential of PCI for atherosclerotic 
plaque imaging. Using a synchrotron-based set-up, high-resolution images can be obtained to evaluate 
the potential of PCI for both qualitatively and quantitatively characterization of plaque features in 
comparison to the gold standard histopathology. However, large-scale synchrotron facilities are not 
suitable for transition to a future clinical application. Therefore a special focus of this thesis was the 
identification and evaluation of plaque using a conventional X-ray source in combination with a three-
grating-based PCI (gb-PCI) set-up developed by Pfeiffer et al.3. For better identification of the different 
vessel wall and plaque components we applied phase-contrast Hounsfield units (HU-phase) to quantify 
the different tissues. 
The idea and concept of the presented studies were developed by the doctoral candidate Sandra Fill 
together with Prof. Tobias Saam, Prof. Fabian Bamberg, Priv.-Doz. Dr. Holger Hetterich, Prof. Franz 
Pfeiffer and Prof. Julia Herzen, who also supervised the whole project. The doctoral candidate was 
responsible for overall coordination of the experiments and data evaluation (coordination of acquisition, 
imaging and histological processing and evaluation of the specimen). The preparation and performance 
of histopathological processing was conducted by the candidate together with a medical technical 
assistant. Imaging of the specimens was conducted at the European Synchrotron Radiation Facility 
(ESRF), Grenoble, France and at the labs of Prof. Franz Pfeiffer at the Technical University Munich. The 
candidate was involved in the imaging process at the Technical University Munich especially in 
preparation of the specimen and definition of the region to be investigated. The candidate was 
responsible for digitalization of the slices, matching of the phase-contrast and histological slices, 
qualitative evaluation and quantitative measurements of vessel wall and plaque components of the phase-
contrast images and histopathological images (including qualitative signal characteristics of vessel wall 
and plaque components, area measurements, comparison of signal-to-noise-ratios in phase-contrast and 
absorption images). The candidate was also responsible for the statistical analysis, in particular 
consolidating different data sources and preparing them for statistical evaluation. The major part of the 
manuscript was written independently by the candidate. In the publication with shared-first authorship 
both the candidate and Priv.-Doz. Dr. Holger Hetterich contributed equally to the publication: The 
candidate was responsible for the above mentioned processes. The identification of relevant tissues for 
HU-phase measurement, data interpretation, in particular of the acquired HU-phase measurements, as 
well as the manuscript writing process was performed by Priv.-Doz. Dr. Hetterich in close cooperation 
with the candidate. Prof. Dr. Dr. h.c. Maximilian Reiser supervised and supported the project. 
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5 Introduction 
5.1 Basic features of atherosclerosis 
Atherosclerosis is a systemic multifactorial disease that affects the arterial vessel wall.  Atherosclerotic 
lesions can lead to cardiovascular events such as cardiovascular disease and acute coronary syndrome, 
cerebrovascular events such as an ischemic stroke and peripheral vascular disease2,4,5. The complex 
pathomechanism of atherosclerosis is based on an imbalance of the lipid metabolism, endothelial 
dysfunction and an inflammatory process4,6. Diseases caused by atherosclerosis like ischemic heart 
disease and stroke account for the majority of deaths worldwide7. 
5.1.1 Physiological composition of the arterial vessel wall 
The arterial vessel wall is basically composed of three parts: the tunica intima adjacent to the vessel 
lumen, the tunica media and the tunica adventitia. This brief introduction to the vessel wall components 
is based on Chapter 5 of the histology textbook by Welsch et al.8. 
Tunica intima 
The tunica intima contains the endothelium, which constitutes the border to the lumen, and underlying 
connective tissue. The plane epithelial cells of the endothelium function as a barrier between blood and 
the tissue of the vessel wall. Therefore, they secrete antithrombogenic factors. They influence the vessel 
tonus by production of vasoconstrictive and vasodilatative factors. The endothelium also plays a role in 
the regulation of inflammation, cellular growth and lipid metabolism, especially the absorption of low-
density lipoprotein (LDL) by LDL receptors. The connective tissue of the intima is composed of 
fibrocytes, collagen type III, elastic fibers and a small number of smooth muscle cells. The tunica intima 
is separated from the tunica media by the lamina elastica interna, an elastic lamella of the tunica media. 
Tunica media 
The tunica media is composed of smooth muscle cells and elastic fibers. Collagen fibers and 
proteoglycans can also occur. The lamina elastic externa forms the outer border to the tunica adventitia. 
Tunica adventitia 
The tunica adventitia is mainly composed of fiber-rich connective tissue. A large number of elastic fibers 
is located at the neighboring region to the media. A reticulum of collagen fibers is also part of the 
adventitia. Small nerves and vasa vasorum can also be found.  
The systemic arteries can be divided into two histological types of arteries: arteries of the elastic type and 
arteries of the muscular type. Large arteries like the aorta and the A. iliaca communis are elastic arteries 
with a so-called windkessel effect. They have a large number of elastic fibers in the tunica media to even 
out blood pressure differences by the pulsatile ejection of the heart, whereas muscular arteries have a 
more regulatory function by their large number of smooth muscle cells in the tunica media.  
5.1.2 Systemic risk factors for atherosclerosis  
The systematic and long-term Framingham study has identified several risk factors for atherosclerotic 
lesions and accompanying diseases9. Factors related with endothelial dysfunction and formation of 
atherosclerotic lesions include modifiable factors such as hypertension, dyslipidemia, smoking, physical 
inactivity and hyperglycemia4,10. Factors which are not modifiable include age, male sex and a genetic 
susceptibility5. The weight of each risk factor for developing a certain disease entity is different. For 
example, the main risk factor for cardiovascular events is the elevation of LDL cholesterol blood 
levels11,12. Smoking and diabetes mellitus have the greatest impact on the risk for peripheral arterial 
disease5. The major risk factor for stroke is hypertension5,12. Genome-wide association studies have 
investigated chromosome loci associated with atherosclerosis-based diseases, such as coronary artery 
disease and stroke13. However, the results have not yet been fully reproducible and the impact and 
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predictive value of the identified loci are still not clear6. The development of atherosclerosis so far is a 
complex and not fully understood interaction of these individually different factors and yet unknown 
parameters. Therefore prediction of vascular events in individuals remains insufficient14. 
5.1.3 Local hemodynamic risk factors for atherosclerosis 
As the whole arterial vessel tree is affected by systemic risk factors, for example elevated cholesterol 
blood levels, smoking or hypertension, one would expect atherosclerotic lesions to be randomly 
distributed throughout the whole vascular system15. However, atherosclerotic lesions cluster, where 
hemodynamic factors like a turbulent instead of laminar flow occur6. The key parameter of the 
hemodynamic factors is the endothelial shear stress, which is a force tangential to the endothelium. It 
depends on the blood viscosity and the spatial gradient of blood velocity over the cross section of the 
vessel15. Low endothelial shear stress is associated with initiation and progression of atherosclerotic 
lesions5. Atherosclerosis prone regions include branch-off points, the outer wall of bifurcations and the 
inner wall of curvatures15. Anatomically the main sites of atherosclerotic lesions are large and medium 
sized arteries like the abdominal aorta, coronary arteries, iliofemoral arteries and carotid bifurcations5. 
The underlying pathogenesis is not fully understood, but implies an interaction between local 
hemodynamic factors with the endothelium leading to a modification of the local protective nitric oxide 
metabolism and a following higher susceptibility of the endothelium to systemic atherogenic factors15.  
5.1.4 Pathogenesis of atherosclerosis 
The initiation of atherosclerosis is to date understood as an interplay between local hemodynamic 
factors, differences in regional arterial development and the modification of the endothelium by 
atherogenic factors like smoking, hypertension and dyslipidemia16. These mechanical and humoral 
factors lead to a dysfunctional endothelium which is prone to the retention of apolipoprotein B (apoB 
LP)17. Dysfunctional endothelial cells represent a specific phenotype concerning their pattern of gene 
expression and mechano-activated signalling pathways17. The incorporation of apoB LPs in the intima 
triggers an aggravation of the pre-existing  dysfunctionality of the endothelium17. These LPs bind to 
proteoglycans in the intima, where these lipoprotein-proteoglycan complexes have a greater 
susceptibility to oxidation18. Oxidated and aggregated apoB LPs act as triggers for an immune response 
by the expression of adhesion molecules, chemoattractants and growth factors in the endothelial cells5. 
Thereby monocytes get attracted and enter the vessel wall and differentiate into macrophages and 
dendritic cells5. By incorporating cholesterol from the retained lipoproteins they turn into foam cells17. 
Lesional macrophages can proliferate and by stimulating pro-inflammatory mediators they amplify the 
inflammatory response, which leads to a plaque progression17. Also other immune cells play a role in the 
complex pathomechanism of atherosclerosis. The role of B cells activated by T cells is not yet fully 
understood. There might be a atheroprotective effect of IgM and IgG19. T cells transmigrate into the 
intima, where they get activated by antigens19. The activated T cells act as an additional pro-
inflammatory trigger. Both macrophages and T cells promote the recruitment and modulation of vascular 
smooth muscle cells19. Smooth muscle cells (SMCs) are specialized contractile cells20. In the vessel wall 
they are the major part of the tunica media. Their function is the regulation of the blood vessel tone20. 
Due to local stimuli such as growth factors, mechanical influences, inflammatory mediators and 
interaction with other cells and the matrix vascular SMCs can undergo a phenotypic modulation20. This 
implies a transformation from a contractile type to a proliferative type20. This dedifferentiated SMC type 
is able to produce a high amount of extracellular matrix components such as collagen, elastin, 
proteoglycans and fibrin20. The dedifferentiated SMCs migrate into the tunica intima, where they 
produce these components, mainly collagen type I to form a fibrous cap (FC) and stabilize the plaque20. 
The SMCs are thus a major part in protection of plaques and healing and repair after arterial injury21. 
However, in an advanced state of the plaque formation macrophages and SMCs produce matrix 
metalloproteases20. The degradation of collagen by metalloproteases and the apoptosis of SMCs lead to a 
destabilization of the FC and increased susceptibility to rupture20. The apoptosis and necrosis of 
macrophages and its insufficient clearance in advanced lesions leads to an accumulation of extracellular 
lipids and cell debris in the center of the plaque, which is also called lipid or necrotic core (NEC) 
covered by the FC22. The formation and invasion of fragile leakage prone neovessels from the adventitial 
vasa vasorum into the plaque is followed by intraplaque bleeding, free cholesterol deposits, immigration 
of inflammatory cells5,23,24. This leads to an expansion and destabilization of the plaque24. Free 
cholesterol can crystallize and thereby contribute to an increase of the NEC and thinning of the FC25. 
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During plaque progression, the arterial wall also undergoes a remodelling process which can result in an 
expansion of the vessel wall without restricting the lumen size26,27. Constrictive remodelling leads to 
vessel shrinkage and narrowing of the lumen. Expansive remodelling is observed more often in rupture-
prone plaques including large lipid accumulations and a high macrophage density26,27. The compensatory 
vessel wall dilating around the eccentric plaque is associated with inflammation, plaque progression and 
plaque rupture, but not so much with stenosis26,27. Constrictive remodelling by adventitial fibrosis and 
wall thickening leads to higher grades of stenosis27. However, it occurs more at stable circumferential 
plaques which are less prone to rupture27.  
5.1.5 The role of calcification 
Vessel wall calcification (CA) can occur as intimal CA associated with atherosclerosis or as medial 
Mönckeberg CA or as arterial CA of the infant28. Each type shows a different pathogenesis and has to be 
considered as an own entity28. The role and pathogenesis of atherosclerotic intimal CA has not yet been 
fully understood. For the risk stratification of cardiovascular events, the amount of CA is often used as a 
predicting factor28. The degree of CA is seen as a marker for the overall plaque burden. Calcifications 
can appear in different morphologies. Most likely CAs originate from apoptotic SMCs and matrix 
vesicles secreted by macrophages as micro-CAs23,28. These micro-CAs often occur in plaques with large 
lipid cores and thin FCs28. The presence of micro-CAs in the FC is discussed to be associated with 
mechanical instability and rupture of the plaque23. Calcifications can progress to large plates and fill out 
the NEC completely5. Some plaques only show fibrous and calcified tissue5. The role of these 
fibrocalcific plaques remains unclear5.  Large CA plates can also fracture and form nodules28. The 
protrusion of these CAs into the plaque lumen is associated with thrombus formation28. Recent 
investigations by Mauriello et al. have shown that stable plaques and healed plaque ruptures show higher 
amounts of CAs than unstable plaques29. The authors suggest that coronary CA  quantification might 
rather determine the vulnerable patient than the vulnerable plaque29. The amount of CA shows 
differences concerning age, sex and race28. Women show less CA than men, especially in the 
premenopausal period28. 50% of patients with asymptomatic carotid atherosclerosis were reported to 
show CAs28,30. Asymptomatic patients undergoing carotid endarterectomy surgery have a higher 
incidence of CAs than symptomatic patients28,31.  
5.1.6 The role of stenosis 
Carotid artery stenosis is accepted as a risk factor for acute events, accounting for 10-20% of strokes or 
transient ischemic attacks32. Patients with a severe stenosis (>50%) of the carotid artery show a 
significantly higher risk for the development of a stroke12,33,34. After a transient ischemic attack the risk of 
stroke within the next 3 months is considered to be 15-20% in the presence of carotid artery stenosis35. 
The degree of carotid artery stenosis is still a major factor in the evaluation of further treatment, namely 
either medical treatment or surgical or interventional carotid revascularization35. However, the degree of 
stenosis alone is an insufficient marker for future acute cardio- or cerebrovascular events12,36. 
Investigations have demonstrated that two-thirds of the patients with acute coronary events show lumen 
narrowing in the region of the culprit lesion of  <50%12,37,38.  
5.1.7 Consequences of atherosclerosis and plaque formation 
The progress of atherosclerosis is subtle and typically remains asymptomatic over decades5. Advanced 
lesions can lead to a narrowing of the vessel lumen cross section with symptomatic stenosis5,22. Stenotic 
lesions are responsible for insufficient perfusion of distal tissues, which manifests as a stable angina 
pectoris for example. However the majority of acute coronary events occur in vessels without critical 
stenosis21,39,40. Plaques can cause the formation of a local thrombus which suddenly occludes the lumen 
or lead to an embolization in distal arteries22. This can be followed by ischemia or infarction of the 
downstream tissue25. Clinical manifestations of atherosclerosis include myocardial infarction, stable and 
instable angina pectoris, sudden coronary death, stroke and transient ischemic attack, peripheral artery 
disease including claudication and critical limb ischemia28.  
5.1.8 Causes for thrombosis 
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To date a model of three pathogenic causes of thrombus formation is widely accepted. In this concept a 
thrombus can develop on the basis of plaque rupture, plaque erosion and calcified nodules protruding 
into the lumen41. In general, ruptured plaques account for around two-thirds, plaque erosion for around 
one-third of thrombotic events, while calcified nodules only play a minor role in the thrombus formation 
process41. Not all ruptured or eroded plaques are followed by an acute event.12 They can heal without 
clinical manifestation12,42,43. Histologically, healed plaques show a pattern of loosely arranged collagen 
III and dens collagen I5. The formation of a fibrous scar is associated with constrictive remodeling5. 
Healed plaques are often associated with high-grade lumen narrowing in coronary arteries5. 
Plaque rupture 
Plaque rupture describes the formation of a defect or gap in the FC which exposes the blood to the 
prothrombogenic cap collagen and the NEC5,22,44. Coagulation proteins in the blood lead to the formation 
of a thrombus which can occlude the vessel lumen locally or embolize in distal arteries25. Plaque ruptures 
take place at the thinnest part of the FC, which is mostly located at the shoulder region5. The thickness of 
a thin FC in coronary arteries is in most cases smaller than 65 µm and in carotid arteries smaller than 
0,25 mm5,45. Atherosclerotic lesions with a FC thickness <65 µm or 0,25 mm respectively and a large 
lipid core are also referred to as thin-cap fibroatheromas46 Plaque rupture develops mostly on the ground 
of SMC and collagen loss on the basis of degradation by infiltrated macrophages5.  
Plaque erosion 
Thrombus formation on the basis of denudation of the endothelium is also called plaque erosion5. Plaque 
erosion is often associated with pathological intima thickening and fibroatheromas with a thick cap5. 
Eroded plaques responsible for sudden cardiac death show only few CAs, negative remodeling  and less 
inflammation than ruptured plaques5. The exposed intima is mainly composed of SMCs and 
proteoglycans46. The pathogenesis of plaque erosion and the following formation of a thrombus remains 
unclear until today5. 
Calcified nodule 
The formation of calcified nodules from broken large calcified plates in the arterial vessel wall was 
explained in section 5.1.5. By protrusion into the lumen and loss and/or dysfunction of overlying 
endothelial cells they are suggested to be able to act as thrombogenic factors5,23,44.  
5.1.9 Concept of vulnerable plaque 
To identify atherosclerotic lesions of patients with a high risk for a sudden thrombotic event apart from 
luminal stenosis the concept of vulnerable versus stable plaque has been established39,40. The American 
cardiologist James E. Muller was the first to use the term “vulnerable plaque” in the field of coronary 
ischemic events in 198935,47. The term vulnerable plaque comprises types of remodeled vessel walls that 
are prone to cause thromboembolic events40. The concept could be transferred from cardiovascular 
events to carotid vascular alterations in patients with ischemic strokes48,49. To distinguish vulnerable 
plaques from stable plaques characteristics for vulnerability have been established40. The following 
features have been identified as vulnerable: thin FC, large lipid or NEC, intraplaque hemorrhage, active 
inflammation with macrophage infiltration and outward remodeling40. There has been a recent 
controversy about the evidence and relevance of the concept of vulnerable plaques14. The impact of 
individual plaque features on the risk of a cardiovascular event might have been overestimated until now. 
The overall plaque burden of an individual might be of greater importance than expected. Also the model 
of the vulnerable plaque has limitations concerning profound in-vivo cause-and-effect data as well as the 
insufficiency of animal models due to differences in plaque composition and progression50. 
5.1.10 Atherosclerosis in cervical carotid arteries, stroke risk and treatment  
Cervical carotid artery atherosclerosis is responsible for 18-25% of strokes25,51,52. To decide if and how a 
patient should be treated to prevent stroke, several criteria have been established25. To date the risk 
stratification of stroke and treatment planning is based on the degree of stenosis and patient symptom 
status.25 Patients with severe stenosis (> 70 %) have a high stroke risk.25 This relation however applies 
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mainly to symptomatic patients25. Patients with asymptomatic carotid stenosis develop strokes in less 
than 2-3% per year and under optimal medical treatment less than 1% annually53. For most of these 
patients medical treatment like lifestyle changes, blood pressure control and statins is the preferred 
choice25,54. For symptomatic patients with severe carotid stenosis (> 70 %), surgical therapy such as 
carotid endarterectomy or carotid artery stenting are the recommended therapy55. For symptomatic 
patients with lower percentage of stenosis (< 70 %) there are still controversies about the best treatment. 
The characterization of vulnerable plaque features has been proposed to allow for better risk stratification 
for cerebrovascular events55. 
5.2 Current status of clinical imaging of carotid atherosclerotic lesions 
Several imaging methods are used for plaque detection25,51,55–58. Each of them inherits advantages as well 
as disadvantages. They can be divided into invasive and noninvasive methods.  
Invasive imaging includes intravascular ultrasound, angioscopy, optical coherence tomography, near-
infrared spectroscopy and intravascular magnetic resonance imaging (MRI). As for all invasive 
procedures, they carry the general risks of bleeding, infection and injury of neighboring tissue structures. 
Non-invasive imaging methods include ultrasound, computed tomography (CT), MRI and molecular 
imaging techniques, such as positron emission tomography (PET) 56. In this summary we will focus on 
non-invasive imaging techniques as PCI is also a non-invasive method.  
In carotid artery plaque detection several factors for vulnerable plaques are well-established56. These 
include plaque ulceration, intraplaque hemorrhage (IPH), thin or ruptured FC, lipid-rich NEC and CAs56.  
5.2.1 Ultrasound 
Ultrasound is an imaging method with the advantages of low costs, high availability, few 
contraindications and absence of ionizing radiation35,56. Disadvantages include high dependence on the 
operator’s skills, local anatomic factors and the lack of independent validation35,56. Ultrasound techniques 
include 2-dimensional (2D) B-mode in combination with color Doppler flow, 3-dimensional (3D) mode 
and contrast-enhanced ultrasound (CEUS).  
The measurement of the carotid intima media thickness (CIMT) is used as a predicting marker for 
cardiovascular risk59–61. CIMT represents the distance between the lumen-intima interface and the media-
adventitia interface which both appear as small echogenic bands divided by the hypoechogenic band of 
the media62. However, measurement methods differ in the various existing studies depending on the 
angle of measurement and on the exact section taken for measurement63. The results of different studies 
concerning the predicting value of CIMT are inconsistent, therefore there is no consensus on the use of 
this method for cardiovascular risk stratification63. Risk assessment for cardiovascular events can be 
improved by additional evaluation of plaque presence63. 
A better predictive value than CIMT can be achieved by evaluation of the plaque burden and its 
progression either by measuring the total plaque area by 2D ultrasound or the total plaque volume by 3D 
ultrasound63. Progression of total plaque volume has been shown to be superior in predicting 
cardiovascular events than total plaque area64. 
In recent years, evaluation of plaque morphology has evolved. Several sonographic features to detect 
vulnerable plaques have been identified as risk factors for ischemic stroke32. The FC can be detected by 
its high echogenicity. Assessment of the thickness of the FC has been reported with moderate sensitivity 
and specificity by the use of stratified grey-scale median (GSM)65. Calcification has a hyperechogenic 
aspect and can be assessed by the mean pixel value, the GSM and the pixel distribution with good 
correlation to histology56,66–68. Calcifications cause sound extinction behind the calcified structures, 
which limits the evaluation of neighboring tissue. Echolucency inside the plaque can be attributed to IPH 
or a lipid-rich NEC and has a strong correlation to a higher risk for ischemic stroke56,69. The sensitivity 
for detection of echolucency is high, however IPH and lipid-rich NEC cannot be differentiated70. 
Neovascularization is supposed to be an initiating factor of IPH and can be visualized by CEUS71,72. 
Neovascularization is a marker for plaque progression and vulnerability73. The size of the echolucency 
was found to be an individual risk marker, as larger lipid-rich NECs appear to be less stable74. Plaque 
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ulceration is defined as a recess of the plaque surface measuring at least 2 mm deep and 2 mm long 
based on a well-defined wall with an area of reversed flow at the site of the recess75.  Ultrasound is not a 
reliable method to detect plaque ulceration, as a wide range of sensitivity (33-75%) and specificity (33-
92%) has been reported56. A simplified definition by Muraki et al. has improved the accuracy of the 
detection of ulceration76. Also CEUS and 3D ultrasound have been reported to be superior in plaque 
surface characterization than 2D ultrasound77,78. 
5.2.2 Computed tomography 
A common non-invasive imaging method for the assessment of the carotid artery is computed 
tomographic angiography (CTA). The application of a contrast agent is necessary to generate contrast 
between the vessel wall and the lumen35. By the use of Hounsfield units radiodensity of different tissues 
can be quantitatively assessed. CTA is widely used for the evaluation of the degree of stenosis of the 
carotid arteries and further treatment planning79. Several plaque components can be identified by CTA, 
however limitations are due to significant overlaps between radiodensities of several components35. 
Other disadvantages of CTA in general are the restrictions and potential adverse effects of the use of 
contrast agents, the exposure to ionizing radiation and the limited visualization of the plaque due to 
artifacts in the presence of heavy CAs35. 
Ulceration defined as “intimal defect larger than 1000 µm in width, exposing the NEC of the 
atheromatous plaque”80 which can be detected by the extension of contrast media from the lumen into 
the plaque can be identified by multidetector row CTA (MDCTA) with good sensitivity and 
specificity81,82. CTA is unable to differentiate between the fibrous cap and the underlying NC. Lipid 
rich cores and IPH appear as hypodense areas and can be detected with good sensitivity and 
specificity, however due to a significant overlap in HU (Hounsfield units) differentiation between IPH 
and lipid-rich core is difficult35,83–86. Calcification appears with a high density and can be detected and 
quantified with high sensitivity by MDCTA56.  
5.2.3 Magnetic resonance imaging 
Magnetic resonance imaging (MRI) offers high soft tissue contrast, high resolution and high 
reproducibility56. MRI currently shows the highest potential in carotid plaque imaging56. Mostly, serial 
images with different contrast weightings are generated for plaque imaging35. Most commonly 1.5-Tesla 
scanners are used56. However 3-Tesla scanners provide a better signal-to-noise ratio and therefore a 
better visualization of plaque components56. 3D-based MRI techniques and molecular MRI are under 
investigation concerning their potential for improving the evaluation of vulnerable plaques56,87. The 
disadvantages of MRI are its higher costs compared to CTA or US and its longer procedure time56. 
Additionally a consensus on the optimal clinically adaptable scan protocol is still missing35. The FC can 
be identified as a juxtaluminal band, hypo- or isointense depending on the sequence56. The nonexistence 
of the band can either be interpreted as a ruptured or thin FC56. A study using a 3D multiple overlapping 
thin slab protocol showed a high capability of discriminating the FC concerning thickness and intact 
versus ruptured surface45. The signal of Lipid-rich-NECs in T1w and T2w- images depends on whether 
they contain IPH or not; in general they appear hypointense on post-contrast enhanced T1w images 
compared to the surrounding fibrous tissue88–92. IPH can be identified as a T1 hyperintense intraplaque 
signal with high sensitivity and specificity with limitations by hemorrhage size and coexisting CA88,93,94. 
Presence of IPH was shown to be a strong predictor of cerebrovascular events95–97. Ulceration can be 
detected as a surface defect in the intimal layer and disorganized blood flow signal with moderate to 
good sensitivity using longitudinal black-blood cardiovascular magnetic resonance angiography98. 
Determination of CAs as a hypointense area in all sequences works with good sensitivity and high 
specificity, although quantifications of the calcified area of the vessel wall tend to be 
underestimated88,90,92.  
5.2.4 Positron emission tomography  
PET is a functional imaging method which can visualize metabolic changes by application of a weakly 
radioactive tracer, mostly 18Fludeoxyglucose (18FDG)56. In 18FDG-PET inflammation in vulnerable 
plaque can be identified directly99. Limitations are the low spatial resolution, non-specific uptake of the 
tracer in the surrounding tissue, high costs and low availability56. By combining PET with CT or MRI 
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limitations concerning anatomical correlations can be addressed56. Single photon emission computed 
tomography can provide additional information about molecular processes inside the plaque, however 
the spatial resolution is inferior to PET56. 
5.3 X-ray-based phase-contrast imaging 
As described above, existing clinical imaging methods of carotid atherosclerosis are limited either by 
insufficient spatial resolution and accuracy 56,63 low soft tissue contrast 35 or high cost56.  X-ray-based 
PCI is expected to combine high spatial resolution of X-radiation as well as sufficient contrast for soft 
tissue materials by sensible detection of  the phase-shift of  X-ray beams100–108. Grating-based PCI (gb-
PCI), which is investigated in this thesis, is a promising PCI method suitable for future clinical practice 
because it can be realized with conventional X-ray sources and therefore at low cost3,109. The utilization 
of conventional X-ray sources makes gb-PCI fully compatible with the established clinical absorption 
radiography, because both conventional absorption images as well as phase-contrast images can be 
recorded simultaneously3. In the following basic principles of PCI are described and an outlook on 
potential medical applications is given. 
5.3.1 Properties of X-radiation 
Since the discovery of X-rays by Conrad Wilhelm Röntgen in 1895 X-ray-based imaging methods have 
evolved to an essential tool in medical diagnostic. X-radiation is defined as the portion of the 
electromagnetic wave spectrum spanning from wavelengths of 10-9 m to 10-11 m 110. The propagation of 
an electromagnetic wave is described by five quantities: wavelength, frequency, velocity, amplitude and 
phase. The amplitude of a wave changes periodically in space and time, where the period length in space 
is the wavelength and the periodicity in time is described by the frequency111. Wavelength and frequency 
have a fixed relation, called the dispersion relation, which depends on the medium of propagation. For 
example, in vacuum, and also as a good approximation in optically dense media, the dispersion is linear, 
i.e. the frequency is proportional to the inverse wavelength and the velocity110,111.  The phase of a wave 
refers to a certain position at a specific time of a wave period. The relation between waves can be 
described by their phase-difference. Coherent waves are referred to as being “in phase”. Waves with 
different phase are called “out of phase”. A wave can also change its phase, for example when it enters a 
medium with a different optical density. X-rays are characteristic for their ability to propagate through 
matter where the penetrated object only absorbs a small fraction of the light, meaning there is a slight 
decrease of amplitude of the X-ray beam110,112. In classical X-ray imaging one only measures the 
intensity, which is the squared time averaged amplitude of the wave. As a consequence, the phase 
information of the X-rays propagating through the object is lost111. The amount of intensity drop is given 
by the Beer-Lambert law, stating that the intensity decreases exponentially with the penetration depth 
and the material-dependent absorption coefficient110,113. The absorption coefficient is wavelength-
dependent and also depends on the atomic number of the penetrated material110,112. In classical X-ray 
methods, the image contrast originates from different absorption coefficients of the materials in the 
sample; e.g. bone tissue has a higher absorption coefficient than soft tissue and thus produces a different 
intensity on the X-ray detector113.  
Either X-ray tubes113 or particle accelerators114,115 are used to generate X-ray light. Both methods are 
based on electron processes110,112. Characteristic for synchrotron radiation is its high brilliance. This 
means that there is a high number of photons per time and spatial angle for a given wavelength of the X-
ray beam115. 
5.3.2 Principles of phase-contrast imaging 
PCI is an X-ray-based method, which has rapidly evolved in the last decades as a new preclinical 
imaging approach with improved soft tissue contrast compared to conventional X-ray techniques116,117. 
X-ray PCI relies on the phase-shift of X-rays in contrast to conventional X-ray methods, which are based 
on the attenuation of the X-ray beam, when passing through matter3. In conventional X-ray images like 
CT contrast relies on differences in the absorption coefficients of the investigated sample118. High 
contrast is achieved for example in samples containing highly absorbing structures like bones embedded 
in poorly absorbing muscle tissue118. However, tissues with lower absorption cross sections like breast 
tissue, vessel walls, muscles cannot be visualized properly with this technique116. For the understanding 
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of PCI it is essential to consider the wave character of light. PCI is based on the phase-shift an X-ray 
beam undergoes when entering and passing through a medium3. Directly related to the phase-shift is an 
angular deviation of the wave front, which means that its propagation velocity and direction are changed 
by the sample, i.e. the X-rays get refracted on the interface of the sample111. One can describe the 
interaction of X-rays with the sample mathematically by the refractive index of the sample which is in 
general a complex number, consisting of a real and imaginary component111:  𝑛 = 1 − 𝛿 + 𝑖𝛽 
Here, δ is the refractive index decrement of the real part of the refractive index and the imaginary 
component β is the extinction coefficient111. 
The real part 1- δ of the refractive index characterizes the phase-shift of the light. For X-rays the real part 
of the refractive index is smaller than one for most materials and therefore expressed by the decrement δ 
of the real part111,113. In vacuum and in very good approximation also in air the refractive index is one113. 
If the X-rays enter from air into a more dense medium such as liquids or solids, i.e. from a medium with 
a higher to a medium with a lower real part of the refractive index, their propagation direction is slightly 
bent away from the surface normal of the interface between the two materials110,111. The extinction 
coefficient which is the imaginary part of the refractive index n specifies the amount of attenuation of the 
X-ray beam during the transmission through the specimen110,111.  
In general, the refractive index depends on the atomic number Z of the material113. For soft tissues, which 
are composed of low Z materials such as hydrogen, carbon, nitrogen and oxygen the magnitude of the 
refractive index contrast is greater than the absorption index contrast108,113. This means that within the 
diagnostic energy range of X-rays PCI is more sensitive for soft tissue than absorption based methods108.  
Different approaches to exploit the phase-shift of the X-ray beam have been established, namely crystal-
interferometry,100,101 analyzer-based imaging,102–104 propagation-based imaging105–107 and grating-based 
interferometry3.  All these methods except for the grating-based PCI (gb-PCI) cannot be realized with 
conventional X-ray sources and require highly brilliant X-ray light e.g. provided by synchrotron 
facilites119. This limits their practical implementation into clinical routine, as only a small number of 
these facilities exist. Gb-PCI, which is investigated in this thesis is a promising PCI method to be 
suitable for future clinical practice because it can be realized with conventional X-ray sources3. 
5.3.3 Grating-based phase-contrast imaging 
Gb-PCI is an interferometric method where two or more gratings are utilized to detect the phase-shift3,109.  
In principle the set-up consists of an X-ray source, the sample, gratings and a detector3. Parts of the 
experiments in this thesis were carried out at a synchrotron facility. For these experiments only two 
gratings are required in total3. When using a lab-based conventional X-ray source the set-up is composed 
of three gratings3. The lab-based set-up includes a source grating G0, a phase grating G1 and an analyser 
grating G23. The source grating is placed behind the X-ray tube and induces the generation of focally 
coherent X-ray sources3. This grating is only relevant to meet the requirements of coherence for the 
detection of the phase-shift by interference3. The sample is placed between the source grating and the 
phase grating3. The phase grating and analyser grating placed behind act as a Talbot interferometer, 
which basically converts interference patterns due to the phase-shift into spatially separated intensity 
variations3. The intensity variations can then be recorded by a standard X-ray detector3. The phase 
grating causes a division of the incoming beam, which will interfere further downstream by formation of 
a fringe pattern 109. Due to the Talbot-Effect the interference pattern created by the phase grating G1 
reoccurs in specific distances, called Talbot-distances120. By use of the analyser grating G2 situated close 
to the detector this pattern is transformed into intensity variations at each pixel of the imaging 
detector3,109. To extract the phase information one of the gratings is stepped parallel to the other gratings 
and the detector121. Tomographic reconstructions are generated from the spatial distribution of the 
refractive index decrement δ(x,y,z) of the sample122. From the same recordings also tomographic 
reconstructions of the distribution of the linear attenuation coefficients can be acquired122. 
For identification of different tissues in conventional X-ray images a quantified grey scale has been 
established. This so-called HU (Hounsfield units) scale is a linear scale based on the linear attenuation 
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coefficient of the tissue with water and air as a reference123. Similarly, phase-contrast Hounsfield units 
(HU-phase) were introduced to scale the refractive index decrement δ122. 
5.3.4 Current status of phase-contrast imaging of vessel structures 
Momose et al. conducted first investigations on the depiction of blood vessels by PCI124. They used a 
crystal interferometer set-up at a synchrotron source to visualize ex-vivo liver specimens freshly excised 
from mice124. The blood vessels were tied to hold the blood inside the specimen124. In these initial results, 
vessels with diameters of about 50 µm could be observed without contrast agents124. However, the vessel 
wall cannot be delineated in these images124. Shinohara et al. were the first to obtain tomographic phase-
contrast images of vessel walls with a crystal X-ray interferometer using a synchrotron source125. They 
could visualize atherosclerotic plaques in ex-vivo vessel specimen of apolipoprotein E-deficient mice.125 
Several plaque features such as the FC and the lipid core could be identified125. Müller et al. could 
demonstrate initial results of a human coronary artery using gb-PCI at a synchrotron source126.  The 
images provide enough contrast to detect the vessel wall, plaque and surrounding fatty tissue126. Holme 
et al. compared images of ex-vivo human coronary arteries obtained by laboratory µCT and gb-PC- at a 
synchrotron source127. They demonstrated a better identification of different tissue structures like foamy 
cells, muscles and plaques in PC-CT images than in µCT images127. Appel et al. compared the 
identification of carotid artery plaques by ultrasound, conventional radiographs and PCI128. In their study 
they investigated patients before carotid endarterectomy by ultrasound and the excised endarterectomy 
specimens by conventional absorption-based radiographs and by using phase-contrast  at a synchrotron 
source128. Phase-contrast images were obtained by a crystal-analyzer set-up128. This study demonstrated 
that phase-contrast images were able to visualize plaque features that could not be seen in ultrasound and 
absorption-based images128. Phase images revealed regions of inflammation, NEC and lipid-rich 
tissue128.  In a similar study, Appel et al. also investigated carotid plaque microstructures by analyzer-
based phase-contrast imaging, where they could identify the interface between plaque and media, regions 
of inflammation and lipid-rich tissue129. In our studies we demonstrate identification of vessel wall layers 
and plaque components in a lab-based setting. The use of a grating-based approach with a conventional 
X-ray source represents an important step towards future clinical application of PCI. Additionally, we 
can show that HU-phase are suitable to quantify and thereby discriminate different tissues similarly to 
the HU scale routinely used in the attenuation-based CT images.  
5.3.5 Recent advances towards medical application and outlook 
A large number of organs and tissues have already been investigated by PCI, including breast130–134, 
cartilage135, lung136137138, liver139–141, renal142, brain143,144, pancreatic145 and lymphatic146 tissues. Currently, 
the technique is still at a preclinical stage at the edge towards first experimental clinical application. A 
big step towards future clinical tomographic phase-contrast recordings has been taken by the 
development of a small animal scanner137. Until recently, all PCI set-ups used a rotating sample for 
tomographic recordings147. In 2012, Tapfer et al. reported the first realization of a gantry-based phase-
contrast set-up147. They were able to take a tomographic scan of a porcine rind sample and identify 
several tissues  including the epidermis, dermis subcutis and muscle tissue147. Scherer et al. could 
optimize a lab-based phase-contrast set-up concerning dose issues and conducted first dose-compatible 
phase-contrast mammography133. Recently Gromann et al. demonstrated first in-vivo full-field chest 
radiographs of a larger mammal at a clinically relevant dose148. In summary, PCI represents a promising 
method for future clinical use if technical problems such as dose-issues, examination-time, cost-effective 
fabrication of the necessary gratings can be overcome 
  
18 
 
 
6  Results 
6.1 Phase-contrast CT: qualitative and quantitative evaluation of atherosclerotic carotid 
artery plaque 
Hetterich H, Willner M, Fill S, Herzen J, Bamberg F, Hipp A, Schüller U, Adam-Neumair S, Wirth S, 
Reiser M, Pfeiffer F, Saam T. Radiology 271, 870-878 (2014). 
https://doi.org/10.1148/radiol.14131554  
6.2 Translation of atherosclerotic plaque phase-contrast CT imaging from synchrotron 
radiation to a conventional lab-based X-ray source 
Saam T, Herzen J, Hetterich H, Fill S, Willner M, Stockmar M, Achterhold K, Zanette I, Weitkamp T, 
Schüller U, Auweter S, Adam-Neumair S, Nikolaou K, Reiser MF, Pfeiffer F, Bamberg F. PLoS One 8, 
e73513 (2013). 
https://doi.org/10.1371/journal.pone.0073513 
6.3 Grating-based X-ray phase-contrast tomography of atherosclerotic plaque at high 
photon energies 
Hetterich H, Fill S, Herzen J, Willner M, Zanette I, Weitkamp T, Rack A, Schüller U, Sadeghi M, Brandl 
R, Adam-Neumair S, Reiser M, Pfeiffer F, Bamberg F, Saam T. Z. Med. Phys. 23, 194–203 (2013). 
https://doi.org/10.1016/j.zemedi.2012.12.001 
  
19 
 
 
7 Abbreviations 
18FDG .......................................... 18Fludeoxyglucose 
2D ............................................... 2-dimensional 
3D ............................................... 3-dimensional 
apoB LP ...................................... apolipoprotein B 
CA ............................................... calcification 
CIMT .......................................... carotid intima media thickness 
CT ............................................... computed tomography 
CEUS .......................................... contrast-enhanced ultrasound 
CTA ............................................ computed tomographic angiography 
ESRF ........................................... European Synchrotron Radiation Facility 
FC ............................................... fibrous cap 
gb-PCI ......................................... grating-based phase-contrast imaging 
GSM ........................................... grey-scale median 
IPH .............................................. intraplaque hemorrhage 
LDL ............................................ low-density lipoprotein 
MDCTA ...................................... multidetector row computed tomographic angiography 
NEC ............................................ necrotic core 
PCI .............................................. phase-contrast imaging 
PC-CT ......................................... phase-contrast computed tomography 
HU .............................................. Hounsfield units 
HU-phase .................................... phase-contrast Hounsfield units 
PET ............................................. positron emission tomography 
SNR ............................................ signal-to-noise ratio 
SMC ............................................ smooth muscle cell  
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